Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation

Recruiting

• Conditions: Cardiogenic Shock; Cardiac Arrest

• Registration Number: NCT04039594
• Lead Sponsor: Beijing Anzhen Hospital

Brief Summary

Venoarterial extracorporeal membrane oxygenation (VA ECMO)-also referred to as extracorporeal life support-is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. The objective of this observational, cohort study is to evaluate the short-term and long-term outcomes of patients with VA ECMO.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-07-30
• Study First Submitted QC: 2019-07-30
• Study First Posted: 2019-07-31
• Status Verified: 2019-08
• Study Start: 2019-08-01
• Last Update Submitted: 2019-08-04
• Last Update Posted: 2019-08-06
• Primary Completion: 2024-07-31
• Study Completion: 2025-07-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Patients receiving VA ECMO for cardiopulmonary support

Exclusion Criteria

Refusal of consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All-cause mortality	30 days

Secondary Outcome Measures

Name	Time	Method
Other complications	30 days	Acute renal failure, ulcer bleeding, pneumonia, sepsis
All-cause mortality	365 days
Rate of successful weaning from ECMO	30 days
Duration stay at ICU and hospital	365 days
ECMO-related complications	30 days	Bleeding requiring transfusion or surgery, stroke, sepsis, limb ischemia requiring intervention, system or cannula change

Trial Locations

Locations (1)

Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University; 🇨🇳 Beijing, Beijing, China